BPC-157 (5mg & 10mg)

BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids, synthesized and lyophilized in the USA. Each production batch is purified through repeated rounds of HPLC and confirmed by mass spectrometry, with certificates of analysis published for every lot.

BPC-157 (5mg & 10mg) is often included in comparative panels alongside other short-chain repair peptides to map functional differences.

Laboratory work on BPC-157 (5mg & 10mg) emphasizes reproducible dosing and purity verification before experimental application.

Current literature on BPC-157 (5mg & 10mg) explores its stability profile and bioactivity under defined buffer and temperature conditions.

This product is available in 5mg and 10mg. Each vial contains lyophilized peptide at the labeled quantity; wholesale orders are packed in boxes of ten vials at a single per-vial price.

Quality assurance: every batch is purified by reversed-phase high-performance liquid chromatography and identity-confirmed by mass spectrometry, with purity above 99%. Lot-specific certificates of analysis are available on request. Store lyophilized vials at -20°C, protected from light and moisture; reconstitute with bacteriostatic water immediately before use and avoid repeated freeze-thaw cycles. For in-vitro laboratory research use only — not for human or veterinary use.

Research & Literature

The following peer-reviewed studies and reference documents are commonly consulted by researchers working with BPC-157 (5mg & 10mg). Summaries are provided for orientation only and reflect the cited sources.

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration^[1] — This study investigated how the pentadecapeptide BPC 157 promotes tendon healing, focusing on tendon outgrowth, cell survival, and cell migration. The results indicated that BPC 157 enhances these cellular processes, suggesting a mechanism through which the peptide may accelerate tendon repair. These findings support research interest in BPC 157 for regenerative and musculoskeletal applications. (Journal of Applied Physiology 2011)

The pharmacological properties of the novel peptide BPC 157 (PL-10)^[2] — This review described the pharmacological properties of the novel peptide BPC 157, also referred to as PL-10, summarizing its reported protective and healing-promoting effects across different tissues. The author discussed evidence suggesting that BPC 157 exerts beneficial actions in models of gastrointestinal and other organ injury. The review established BPC 157 as a pentadecapeptide with broad cytoprotective potential. (Inflammopharmacology 1999)

PubChem Compound Summary for CID 9941957, Bpc-157^[3] — PubChem catalogs the chemical identity of BPC-157, including its molecular formula, structure, and known physicochemical properties. The entry provides reference data on this pentadecapeptide for researchers. It serves as a standard database record for the compound. (PubChem 2026)

References

1. Chang CH, et al.. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." Journal of Applied Physiology. 2011. pubmed.ncbi.nlm.nih.gov/21030672/
2. Sikiric P. "The pharmacological properties of the novel peptide BPC 157 (PL-10)." Inflammopharmacology. 1999. pubmed.ncbi.nlm.nih.gov/17657443/
3. National Center for Biotechnology Information. "PubChem Compound Summary for CID 9941957, Bpc-157." PubChem. 2026. pubchem.ncbi.nlm.nih.gov/compound/Bpc-157

All products are supplied as lyophilized powder for in-vitro laboratory research use only and are not for human or veterinary use.